The North American life science instrumentation market is projected to grow at a significant CAGR of around 6.4% during the forecast period (2021-2027). One of the major factors that propel the market growth is the significant presence of major market players such as Becton, Dickinson and Co., General Electric Co., Bio-Rad Laboratories, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., and others in the region. These companies are contributing significantly to the life science instrumentation market by investing in research activities and pharmaceutical drug discoveries. North America has a well-developed healthcare infrastructure, owing to which, companies are investing in the development of advanced solutions for the life science market.
To Request a Sample of our Report on North American Life Science Instrumentation Market: https://www.omrglobal.com/request-sample/north-american-life-science-instrumentation-market
Furthermore, in May 2018, General Electric Co. introduced Sefia S-2000 instrument that allows streamlining cellular products processes, such as isolation, harvesting, and final formulation. This enables to streamline the workflow and by the intuitive user design, the researcher can establish a protocol to automatically run in sequence. The functionally closed processing enables the removal of contaminants and sensor controls, and automation allows to ensure smooth operations. This facilitates record-keeping and compliance with the requirements. Traceability provides records to meet the needs of environmental monitoring. Therefore, these offering by the major market players in the region providing ample opportunity for the growth of the life science market in the near future.
(Get 15% Discount on Buying this Report)
A full Report of North American Life Science Instrumentation Market is Available at: https://www.omrglobal.com/industry-reports/north-american-life-science-instrumentation-market
North American Life Science Instrumentation Market – Segmentation
By Technology
· Chromatography
· Spectroscopy
· Polymerase Chain Reaction (PCR)
· Clinical Chemistry Analyzers
· Immunoassays
· Next-Generation Sequencing (NGS)
· Flow Cytometry
· Microscopy
· Others (Centrifuges, Electrophoresis)
By End-User
· Pharmaceutical & Biotechnology Companies
· Research Institutes
· Hospitals and Laboratories
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
